BFA
LGND icon

BlackRock Fund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

BlackRock Fund Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$180M Buy
2,841,646
+301,221
+12% +$19M 0.03% 741
2016
Q3 		$162M Buy
2,540,425
+189,678
+8% +$13.9M 0.03% 675
2016
Q2 		$175M Buy
2,350,747
+143,410
+6% +$10.6M 0.04% 571
2016
Q1 		$147M Buy
2,207,337
+38,422
+2% +$2.34M 0.03% 655
2015
Q4 		$147M Buy
2,168,915
+813
+0% +$50.2K 0.03% 674
2015
Q3 		$116M Buy
2,168,102
+119,664
+6% +$7.26M 0.03% 790
2015
Q2 		$129M Sell
2,048,438
-88,374
-4% -$4.82M 0.03% 790
2015
Q1 		$103M Buy
2,136,812
+89,715
+4% +$3.44M 0.02% 980
2014
Q4 		$68M Buy
2,047,097
+58,338
+3% +$1.9M 0.02% 1245
2014
Q3 		$58.3M Sell
1,988,759
-93,379
-4% -$3.1M 0.02% 1259
2014
Q2 		$80.9M Sell
2,082,138
-89,927
-4% -$3.65M 0.02% 1059
2014
Q1 		$91.2M Buy
2,172,065
+59,024
+3% +$2.46M 0.03% 926
2013
Q4 		$69.3M Buy
2,113,041
+950,194
+82% +$31M 0.02% 1150
2013
Q3 		$31.4M Buy
1,162,847
+149,783
+15% +$4.21M 0.01% 1662
2013
Q2 		$23.6M Buy
+1,013,064
New +$18.2M 0.01% 1734

Other funds holding LGND

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Fund Advisors's LGND Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Ligand Pharmaceuticals (LGND) stake by 12% in Q4 2016, buying an estimated $19M and bringing the position to 2,841,646 shares worth $180M. The position accounts for 0.03% of the portfolio, ranked #741.

BlackRock Fund Advisors first reported a position in LGND in Q2 2013 and has held it in 15 quarters since. 270 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

  • BlackRock Fund Advisors held 2,841,646 shares of Ligand Pharmaceuticals worth $180M as of Q4 2016.
  • BlackRock Fund Advisors bought 301,221 Ligand Pharmaceuticals shares in Q4 2016, an estimated $19M.
  • Ligand Pharmaceuticals made up 0.03% of BlackRock Fund Advisors's portfolio in Q4 2016, its #741 holding.
  • BlackRock Fund Advisors first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 270 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.